Plasma Oligomeric Beta Amyloid in Alzheimer’s Disease with History of Agent Orange Exposure
활용도 Analysis
논문 Analysis
연구자 Analysis
'
Plasma Oligomeric Beta Amyloid in Alzheimer’s Disease with History of Agent Orange Exposure' 의 참고문헌
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging- Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Soluble <TEX>$A{\beta}$</TEX> oligomer production and toxicity
Self-reported health status of Vietnam veterans in relation to perceived exposure to herbicides and combat
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment
Neuropsychological effects of chronic exposure to environmental dioxins and furans
Neurological and neurophysiological examinations on workers with chronic poisoning by 2,3,7,8-TCDD: follow-up 35 years after exposure
Neurodegenerative diseases and exposure to pesticides in the elderly
Neonatal hypomyelination by the herbicide 2,4-dichlorophenoxyacetic acid. Chemical and ultrastructural studies in rats
Morbidity follow up study of BASF employees exposed to 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident
Monoclonal antibodies that target pathological assemblies of Abeta
Measurement of <TEX>$A{\beta}$</TEX> oligomer in plasma and a significant correspondence to diagnosis of CSF biomarkers and PIB-PET
Magnetic microparticle-based multimer detection system for the detection of prion oligomers in sheep
Is Parkinson’s Disease with History of Agent Orange Exposure Different from Idiopathic Parkinson’s Disease?
Environmental pesticide exposure as a risk factor for Alzheimer's disease: a case-control study
Electrochemical immunosensors for effective evaluation of amyloid-beta modulators on oligomeric and fibrillar aggregation processes
Differentiating blood samples from scrapie infected and non-infected hamsters by detecting disease-associated prion proteins using Multimer Detection System
Developing novel blood-based biomarkers for Alzheimer's disease
Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures
Brain amyloid-<TEX>${\beta}$</TEX> oligomers in ageing and Alzheimer's disease
Blood-based protein biomarkers for diagnosis of Alzheimer disease
Association between the levels of biogenic amines and superoxide anion production in brain regions of rats after subchronic exposure to TCDD
Amyloid oligomers: formation and toxicity of Abeta oligomers
Alzheimer's disease-affected brain: presence of oligomeric A <TEX>${\beta}$</TEX> ligands (ADDLs) suggests a molecular basis for reversible memory loss
Agent Orange exposure and disease prevalence in Korean Vietnam veterans: the Korean veterans health study
A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's disease
2, 3, 7, 8-Tetrachlorodibenzo-P-dioxin (TCDD) induces premature senescence in human and rodent neuronal cells via ROS-dependent mechanisms
'
Plasma Oligomeric Beta Amyloid in Alzheimer’s Disease with History of Agent Orange Exposure'
의 유사주제(
